- Health and well-being
Google
The FinPharma Autumn Research Seminar presents a wide variety of the research within the FinPharma network, which brings together the pharmaceutical drug research of the University of Helsinki, the University of Eastern Finland, and Åbo Akademi University.
Program
10:00–10:05 Opening words, Raimo Tuominen, University of Helsinki
10:05–10:30 Screening drug molecules to target pre-microRNA-16, Piia Bartos, School of Pharmacy, University of Eastern Finland
10:30–10:55 Discovery & development of selective Kv7 potassium channel agonists, Peter Wipf, School of Pharmacy, University of Eastern Finland & Department of Chemistry, University of Pittsburgh
10:55–11:20 Medication errors and risk management – what can we learn? Anna-Riia Holmström, Drug Research Program, Faculty of Pharmacy, University of Helsinki
11:20–11:45 Dressing up viruses to fool cancer, Vincenzo Cerullo, Drug Research Program, Faculty of Pharmacy, University of Helsinki
11:45–12:35 Lunch break
12:35–13:00 PREP ligands – a therapy for several neurodegenerative diseases, Timo Myöhänen, School of Pharmacy, University of Eastern Finland
13:00–13:25 Physiological basis underlying antidepressant-induced activation of TrkB receptors, Tomi Rantamäki, Drug Research Program, Faculty of Pharmacy, University of Helsinki
13:25–13:50 Use of adeno-associated virus and lentivirus vectors in pharmacological research: advantages and disadvantages, Mikko Airavaara, Drug Research Program, Faculty of Pharmacy, University of Helsinki
13:50–14:15 Protein-based therapies for Parkinson’s disease: challenges and future considerations, Merja Voutilainen, Drug Research Program, Faculty of Pharmacy, University of Helsinki
14:15–14:25 Coffee break
14:25–14:50 Mechanistic insight into cardiac regeneration and remodelling – better cardiovascular drugs in the future? Virpi Talman, Drug Research Program, Faculty of Pharmacy, University of Helsinki
14:50-15:15 Unveiling hidden drug toxicities via microfluidics-assisted drug metabolism research, Tiina Sikanen, Drug Research Program, Faculty of Pharmacy, University of Helsinki
15:15–15:40 Inhibitory catecholaminergic targeting slows neurodegeneration of the retina, Henri Leinonen, Center for Translational Vision Research, School of Pharmacy, University of Eastern Finland
15:40–16:05 A hyperbright tag for the real-time in-vivo tracing of low-abundance secreted proteins, Michael Jeltsch, Drug Research Program, Faculty of Pharmacy, University of Helsinki
16:05–16:10 Closing words, Raimo Tuominen, University of Helsinki
A link to participation will be sent by email to all registered. Welcome!
